A High-Performance Passive Radiative Cooling Metafabric with Janus Wettability and Thermal Conduction.

With the development of industry and global warming, passive radiative cooling textiles have recently drawn great interest owing to saving energy consumption and preventing heat-related illnesses. Nevertheless, existing cooling textiles often lack efficient sweat management capacity and wearable comfort under many practical conditions. Herein, a hierarchical cooling metafabric that integrates passive radiation, thermal conduction, sweat evaporation, and excellent wearable comfort is reported through an electrospinning strategy. The metafabric presents excellent solar reflectivity (99.7%, 0.3-2.5 µm) and selective infrared radiation (92.4%, 8-13 µm), given that the unique optical nature of materials and wettability gradient/micro-nano hierarchical structure design. The strong moisture-wicking effect (water vapor transmission (WVT) of 2985 g m-2 d-1 and directional water transport index (R) of 1029.8%) and high heat-conduction capacity can synergistically enhance the radiative cooling efficiency of the metafabric. The outdoor experiment reveals that the metafabric can obtain cooling temperatures of 13.8 °C and 19.3 °C in the dry and sweating state, respectively. Meanwhile, the metafabric saves ≈19.3% of annual energy consumption compared with the buildings with HAVC systems in Shanghai. The metafabric also demonstrates desirable breathability, mechanical strength, and washability. The cost-effective and high-performance metafabric may offer a novel avenue for developing next-generation personal cooling textiles.

Preparation and anti-tumor activity of paclitaxel silk protein nanoparticles encapsulated by biofilm.

In order to overcome the poor bioavailability of paclitaxel (PTX), in this study, self-assembled paclitaxel silk fibronectin nanoparticles (PTX-SF-NPs) were encapsulated with outer membrane vesicles of Escherichia coli (E. coil), and biofilm-encapsulated paclitaxel silk fibronectin nanoparticles (OMV-PTX-SF-NPs) were prepared by high-pressure co-extrusion, the size and zeta potential of the OMV-PTX-SF-NPs were measured. The antitumor effects of OMV-PTX-SF-NPs were evaluated by cellular and pharmacodynamic assays, and pharmacokinetic experiments were performed. The results showed that hydrophobic forces and hydrogen bonding played a major role in the interaction between paclitaxel and filipin proteins, and the size of OMV-PTX-SF-NPs was 199.8 ± 2.8 nm, zeta potential was -17.8 ± 1.3 mv. The cellular and in vivo pharmacokinetic assays demonstrated that the OMV-PTX-SF-NPs possessed a promising antitumor effect. Pharmacokinetic experiments showed that the AUC0-∞ of OMV-PTX-SF-NPs was 5.314 ± 0.77, which was much larger than that of free PTX, which was 0.744 ± 0.14. Overall, we have successfully constructed a stable oral formulation of paclitaxel with a sustained-release effect, which is able to effectively increase the bioavailability of paclitaxel, improve the antitumor activity, and reduce the adverse effects.

Asymmetrical Emissivity and Wettability in Stitching Treble Weave Metafabric for Synchronous Personal Thermal-Moisture Management.

Developing textiles with passive thermal management is an effective strategy to maintain the human body healthy as well as decrease energy consumption. Personal thermal management (PTM) textiles with engineered constituent element and fabric structure have been developed, however the comfortability and robustness of these textiles remains a challenge due to the complexity of passive thermal-moisture management. Here a metafabric with asymmetrical stitching treble weave based on woven structure design and yarn functionalization is developed, in which the thermal radiation regulation and moisture-wicking can be achieved simultaneously throughout the dual-mode metafabric due to its optically regulated property, multi-branched through-porous structure and surface wetting difference. With simply flipping, the metafabric enables high solar reflectivity (87.6%) and IR emissivity (94%) in the cooling mode, and a low IR emissivity of 41.3% in the heating mode. When overheating and sweating, the cooling capacity reaches to ≈9 °C owing to the synergistic effect of radiation and evaporation. Moreover, the tensile strengths of the metafabric are 46.18 MPa (warp direction) and 37.59 MPa (weft direction), respectively. This work provides a facile strategy to fabricate multi-functional integrated metafabrics with much flexibility and thus has great potential for thermal management applications and sustainable energy.

Thermodynamically Induced Interfacial Condensation for Efficient Fog Harvesting.

Fog harvesting is a sustainable approach to dealing with the global freshwater crisis. A range of strategies in microstructure design and wettability remodeling for fog management are clearly explained. However, the influence of thermodynamic endothermic and exothermic processes on fog harvesting is rarely explored. Here, a thermodynamically induced interfacial condensation-enhanced fog-harvesting fabric (AWF-6) is developed that also incorporates asymmetric geometry and surface chemistry. By coupling the high thermal conductivity interface supported by boron nitride nanosheets (BNNS), the Laplace pressure difference generated by nanoneedles, and the wettability gradient constructed by stearic acid (STA), the fabric achieves a water collection rate (WCR) of 1538.4 mg h cm-2 , which is the maximum value in state-of-the-art cotton-based fog harvesting devices (FHDs). Furthermore, the potential application of AWF-6 in agricultural irrigation is demonstrated. This study shows a thermodynamic proposal for building next-generation fibrous FHDs.

Albumin Nanoparticle-Based Drug Delivery Systems.

Nanoparticle-based systems are extensively investigated for drug delivery. Among others, with superior biocompatibility and enhanced targeting capacity, albumin appears to be a promising carrier for drug delivery. Albumin nanoparticles are highly favored in many disease therapies, as they have the proper chemical groups for modification, cell-binding sites for cell adhesion, and affinity to protein drugs for nanocomplex generation. Herein, this review summarizes the recent fabrication techniques, modification strategies, and application of albumin nanoparticles. We first discuss various albumin nanoparticle fabrication methods, from both pros and cons. Then, we provide a comprehensive introduction to the modification section, including organic albumin nanoparticles, metal albumin nanoparticles, inorganic albumin nanoparticles, and albumin nanoparticle-based hybrids. We finally bring further perspectives on albumin nanoparticles used for various critical diseases.

Albumin appears to be a promising carrier for drug delivery with superior biocompatibility and enhanced targeting capacity. This review focuses on the importance of albumin nanoparticles in drug delivery and concludes the recent fabrication techniques to prepare albumin nanoparticles, the modification strategies to require functional albumin nanoparticles, and critical applications of albumin nanoparticles in various diseases. The aim of this review is to help readers understand the significant potential of albumin nanoparticles in drug delivery.

Analysis of electroencephalography characteristics during walking in stroke patients under different conditions: a cross-sectional study.

Aims/Background Backward walking is gaining traction in rehabilitation therapy, showing promise as an intervention for stroke patients with walking difficulties. However, the brain activity patterns (neurophysiological mechanisms) underlying backward walking in these patients remain unclear. This study investigated the neurophysiological mechanism in stroke patients within 1 year of their stroke. Methods Twenty-four subjects walked forward and backward for 5 min on an 8-m track while their electroencephalographic signals were collected. The power values of each frequency band were compared during forward and backward walking, and the delta to alpha power ratio (DAR) was calculated. Results The results showed a significant increase in α-band activity within the frontal cortex during backward walking (p < 0.05). This increase correlated positively with scores on the Fugl-Meyer lower extremity motor function assessment scale. Similarly, α-band activity showed significant enhancement within the right parietal cortex during backward walking (p < 0.05). There were no significant differences between forward and backward walking states in δ, θ, and ß wavebands across the entire brain region (p > 0.05). Additionally, the DAR was significantly lower during backward walking than during forward walking (p < 0.05). Conclusion This study suggests that backward walking may more effectively activate neural activity in the prefrontal and right posterior parietal cortices. This finding supports the potential of backward walking to enhance motor execution and walking function in stroke patients, thereby supporting its application as a rehabilitation method.

Complete System to Generate Clean Water from a Contaminated Water Body by a Handmade Flower-like Light Absorber.

The utilization of solar energy to make human lives better has been one of the primary and green approaches adopted by ordinary people and researchers for decades. This approach has recently gained a lot of attention as a way to tackle clean water scarcity in remote areas. Costly components, complex manufacturing procedures with rarely available equipment, and a surface to condense water vapors are challenges in the way of its application in the required areas. Here, we propose a complete system to solve this problem with a handmade light absorber and a superhydrophilic surface (antifogging) to get vapors back to collect clean water. Our handmade flower-like light absorber stitched by crochet work, the single stitch method, was able to get a decent evaporation rate of 1.75 kg/m2·h in pure water and slightly lower rates of 1.62 and 1.65 kg/m2·h with brine and pond water, respectively. Still, our proposed superhydrophilic coated surface can collect ∼37% more water than the pristine surface. This system has a huge potential for use in rural areas because of multiple key advantages, such as simple technology, readily available low-cost raw materials, and easy fabrication.

SAR Investigation and Discovery of Water-Soluble 1-Methyl-1,4-dihydroindeno[1,2-c]pyrazoles as Potent Tubulin Polymerization Inhibitors.

Taking the previously discovered 1-methyl-1,4-dihydroindeno[1,2c]pyrazol derivative LL01 as a lead, systematic structural modifications were made at the phenolic 6- and 7-positions and the aniline at the 3-position of the indenopyrazole core to investigate the SARs and to improve water solubility. Among the designed indenopyrazoles ID01-ID33, a series of potent MTAs were identified. As the hydrochloride salt(s), ID09 and ID33 showed excellent aqueous solubility and favorable Log P value and displayed noteworthily low nanomolar potency against a variety of tumor cells, including those taxol-resistant ones. They inhibited tubulin polymerization, disrupted cellular microtubule networks by targeting the colchicine site, and promoted HepG2 cell cycle arrest and cell apoptosis. In the HepG2 xenograft mouse model, ID09 and ID33 effectively inhibited tumor growth at an oral dose of 25 mg/kg. At an intravenous (iv) injection dose of 10 mg/kg every other day, ID09 suppressed tumor growth by 68% without obvious toxicity.

Design, Synthesis, and Biological Evaluation of 1-Methyl-1,4-dihydroindeno[1,2-c]pyrazole Analogues as Potential Anticancer Agents Targeting Tubulin Colchicine Binding Site.

By targeting a new binding region at the interface between αß-tubulin heterodimers at the colchicine binding site, we designed a series of 7-substituted 1-methyl-1,4-dihydroindeno[1,2-c]pyrazoles as potential tubulin polymerization inhibitors. Among the compounds synthesized, 2-(6-ethoxy-3-(3-ethoxyphenylamino)-1-methyl-1,4-dihydroindeno[1,2-c]pyrazol-7-yloxy)acetamide 6a and 2-(6-ethoxy-3-(3-ethoxyphenylamino)-1-methyl-1,4-dihydroindeno[1,2-c]pyrazol-7-yloxy)-N-hydroxyacetamide 6n showed noteworthy low nanomolar potency against HepG2, Hela, PC3, and MCF-7 cancer cell lines. In mechanism studies, 6a inhibited tubulin polymerization and disorganized microtubule in A549 cells by binding to tubulin colchicine binding site. 6a arrested A549 cells in G2/M phase that was related to the alterations in the expression of cyclin B1 and p-cdc2. 6a induced A549 cells apoptosis through the activation of caspase-3 and PARP. In addition, 6a inhibited capillary tube formation in a concentration-dependent manner. In nonsmall cell lung cancer xenografts mouse model, 6a suppressed tumor growth by 59.1% at a dose of 50 mg/kg (ip) without obvious toxicity, indicating its in vivo potential as anticancer agent.

Tubulin colchicine binding site inhibitors as vascular disrupting agents in clinical developments.

Tumor vasculature is an important target in cancer treatment. Two distinct vasculartargeting therapeutic strategies are applied to attack cancer cells indirectly. The antiangiogenic approach intervenes in the neovascularization processes and blocks the formation of new blood vessels, while th e antivascular approach targets the established tumor blood vessels, making vascular shutdown and resulting in rapid haemorrhagic necrosis and tumor cell death. A number of compounds with diverse structural scaffolds have been designed to target tumor vasculature and they are called vascular disrupting agents (VDAs). The biological or ligand-directed VDAs utilize antibodies, peptides or growth factors to deliver toxins or pro-coagulants or proapoptotic affectors to tumor-related blood vessels, while the small-molecule VDAs selectively target tumor blood vessels and have little effects on the normal endothelium. Among the small-molecule VDAs, the tubulin colchicine binding site inhibitors have been extensively studied and many of them have entered the clinical trials, including CA-4P, CA-1P, AVE8062, OXi4503, CKD-516, BNC105P, ABT-751, CYT- 997, ZD6126, NPI-2358, MN-029 and EPC2407. This review makes a summary of the small-molecule VDAs in clinical developments and highlights some potential VDA leads or candidates for the treatment of tumors.